Davita Calls Whistleblowers' FCA Kidney Drugs Suit Flawed

By Linda Chiem · August 15, 2014, 3:24 PM EDT

Davita Inc. urged a Georgia federal court on Thursday to toss a whistleblower suit alleging it bilked taxpayers by seeking reimbursement for intentionally overused or wasted dialysis drugs, saying its dosing...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Reply Brief

Case Information

Case Title

United States of America Ex Rel et al v. Davita, Inc. et al

Case Number

Court

Georgia Northern

Nature of Suit

Other Fraud

Date Filed

October 11, 2007

Recent Articles By Linda

August 29, 2023
9th Circ. Revives Challenge To SF Healthy Airport Ordinance
August 16, 2023
EPA Downplayed Risks After Ohio Train Derailment, Court Told
July 17, 2023
United Eyes Exit Amid Class Cert. Bid In COVID Refund Suit
February 17, 2023
Feds Vow To Hold Norfolk Southern Accountable In Derailment
October 06, 2022
Split 11th Circ. Backs Florida Vaccine Passport Ban
August 29, 2022
Norfolk Southern Rips Pa. Jurisdiction Law As Relic
August 18, 2022
Full 5th Circ. Won't Rehear United Vaccine Mandate Row
August 01, 2022
11th Circ. Urged To Back Ruling Ending CDC Mask Mandate
July 12, 2022
Norfolk Southern Can't Evade Pa. Jurisdiction, Justices Told
May 02, 2022
Separate Fla. Judge Backs CDC Mask And Testing Mandates